These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 1715265)
1. Prophylactic treatment regimens for the prevention of hepatitis A. Current concepts. Kendall BJ; Cooksley WG Drugs; 1991 Jun; 41(6):883-8. PubMed ID: 1715265 [TBL] [Abstract][Full Text] [Related]
2. Prevention of viral hepatitis A: past, present and future. Deinhardt F Vaccine; 1992; 10 Suppl 1():S10-4. PubMed ID: 1335635 [TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness analysis of vaccination against hepatitis A in travellers. Van Doorslaer E; Tormans G; Van Damme P J Med Virol; 1994 Dec; 44(4):463-9. PubMed ID: 7897383 [TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness analysis of hepatitis A prevention in travellers. Tormans G; Van Damme P; Van Doorslaer E Vaccine; 1992; 10 Suppl 1():S88-92. PubMed ID: 1335668 [TBL] [Abstract][Full Text] [Related]
6. Who should receive hepatitis A vaccine? Considerations for the development of an immunization strategy. Margolis HS; Shapiro CN Vaccine; 1992; 10 Suppl 1():S85-7. PubMed ID: 1335667 [TBL] [Abstract][Full Text] [Related]
7. Tourist hepatitis, antibodies to hepatitis A virus and immune serum globulin prophylaxis. Iwarson S; Frösner G; Norkrans G Infection; 1978; 6(6):257-8. PubMed ID: 215556 [TBL] [Abstract][Full Text] [Related]
8. Effect of postexposure vaccination in a chimpanzee model of hepatitis A virus infection. Robertson BH; D'Hondt EH; Spelbring J; Tian H; Krawczynski K; Margolis HS J Med Virol; 1994 Jul; 43(3):249-51. PubMed ID: 7931186 [TBL] [Abstract][Full Text] [Related]
9. Perspectives on the control of hepatitis A by vaccination. Kane MA Vaccine; 1992; 10 Suppl 1():S93-6. PubMed ID: 1335670 [TBL] [Abstract][Full Text] [Related]
10. Control of hepatitis A by inactivated vaccines: unanswered questions and unresolved issues. Purcell RH J Hepatol; 1993; 18 Suppl 2():S61-4. PubMed ID: 8182277 [TBL] [Abstract][Full Text] [Related]
11. Anti-HAV seroprevalence in German travellers and hepatitis A vaccination in immune subjects. Bienzle U; Bock HL; Meister W; Clemens R; Kruppenbacher JP Lancet; 1993 Apr; 341(8851):1028. PubMed ID: 8096914 [No Abstract] [Full Text] [Related]
12. Adult use of hepatitis A vaccine in developed countries. Jilg W Vaccine; 1993; 11 Suppl 1():S6-8. PubMed ID: 8383389 [TBL] [Abstract][Full Text] [Related]
13. Immunisation against hepatitis A--active or passive? Iwarson S Infection; 1996; 24(1):2-4. PubMed ID: 8852454 [No Abstract] [Full Text] [Related]
14. Prophylactic efficacy of immune serum globulin against hepatitis A. Ohara H; Ebisawa I; Ohtani S Jpn J Exp Med; 1986 Oct; 56(5):229-33. PubMed ID: 3027432 [TBL] [Abstract][Full Text] [Related]
15. [Effect of the content of hepatitis A antibodies in immunoglobulin preparations on the effectiveness of the immunoglobulin prophylaxis of hepatitis A]. Gorbunov MA; Sumarokov AA; Iaroshevskaia IIu; Ikoev VN; Khalitova KA Zh Mikrobiol Epidemiol Immunobiol; 1984 Jun; (6):86-9. PubMed ID: 6087581 [TBL] [Abstract][Full Text] [Related]
17. Passive immunization against hepatitis A. Stapleton JT Vaccine; 1992; 10 Suppl 1():S45-7. PubMed ID: 1335658 [TBL] [Abstract][Full Text] [Related]
18. [Vaccination against hepatitis A]. Balli F; Di Biase AR; Viola L Pediatr Med Chir; 1996; 18(3):259-62. PubMed ID: 8966125 [TBL] [Abstract][Full Text] [Related]
19. Testing for antibody to hepatitis A to decrease the cost of hepatitis A prophylaxis with immune globulin or hepatitis A vaccines. Bryan JP; Nelson M Arch Intern Med; 1994 Mar; 154(6):663-8. PubMed ID: 8129500 [TBL] [Abstract][Full Text] [Related]